(Q34136515)

31 July 2017

1 reference

title

Biology of transforming growth factor beta in hepatocarcinogenesis (English)

1 reference

31 July 2017

Rossmanith W

1

1 reference

31 July 2017

Schulte-Hermann R

series ordinal

2

1 reference

31 July 2017

publication date

1 February 2001

1 reference

Microscopy Research and Technique

31 July 2017

published in

1 reference

31 July 2017

volume

52

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

430-436

1 reference

The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Inhibition of transforming growth factor beta1-induced hepatoma cell apoptosis by liver tumor promoters: characterization of primary signaling events and effects on CPP32-like caspase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Mitochondrial membrane permeabilization during the apoptotic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

The role of activin and transforming growth factor-beta in the regulation of organ mass in the rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Regulation of immune responses by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Phenobarbital selectively promotes initiated cells with reduced TGF beta receptor levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Follistatin: a multifunctional regulatory protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Transforming growth factor-beta receptors type I, II and III in phenobarbital-promoted rat liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Critical stages of tumor growth regulation in transgenic mice harboring a hepatocellular carcinoma revealed by distinct patterns of tumor necrosis factor-alpha and transforming growth factor-beta mRNA production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Chemical hepatocarcinogenesis in transgenic mice overexpressing mature TGF beta-1 in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Serial killers: ordering caspase activation events in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Mutation analysis of the transforming growth factor beta type II receptor in sporadic human cancers of the pancreas, liver, and breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0029%2820010215%2952%3A4%3C430%3A%3AAID-JEMT1028%3E3.0.CO%3B2-3

10.1002/1097-0029(20010215)52:4<430::AID-JEMT1028>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference